DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Companies / Solstice Oncology, Inc.
Solstice Oncology, Inc.
Stage unknownBoston, MABiotechnology
Facts
Financing history
1 rounds
- Feb 20, 2026Form D equity offering · $121M (form d sold) · 8 investorsFact SEC EDGAR Form D data sets (quarterly) · “Solstice Oncology, Inc. filed Form D: $121,260,306 sold of $298,400,851, Biotechnology”
Investors on record
0 edges
No named investor yet.
People
3 officers, 4 directors
- Caroline Loew Executive Officer/Director/Promoter sec.gov
- David Feltquate Executive Officer sec.gov
- Maiken Keson-Brookes Executive Officer sec.gov
- Andrew Levin Director Fact
- Julie Grant Director Fact
- Emily Minkow Director Fact
- Morgan Haller Director Fact
Timeline
1
- Mar 9, 2026Solstice Oncology, Inc. filed Form D: $121,260,306 sold of $298,400,851, BiotechnologyForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
15 observations
Every observation on this company
- Entity type: Corporation Mar 9, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Biotechnology Mar 9, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false Mar 9, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Mar 9, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: withinFiveYears Mar 9, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Mar 9, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $121M Mar 9, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $298M Mar 9, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Mar 9, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2026-02-20 Mar 9, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 8 Mar 9, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Mar 9, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity,option Mar 9, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 200 BERKELEY ST., 18TH FLOOR, BOSTON, MA, 02116 Mar 9, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Year of incorporation: 2026 Mar 9, 2026 Fact SEC EDGAR Form D data sets (quarterly)